Hologic (HOLX) Tops Q1 EPS by 1c

Hologic (NASDAQ: HOLX) reported Q1 EPS of $0.58, $0.01 better than the analyst estimate of $0.57. Revenue for the quarter came in at $830.7 million versus the consensus estimate of $817.94 million.

GUIDANCE:

Hologic sees Q2 2019 EPS of $0.55-$0.57, versus the consensus of $0.58.

Hologic sees FY2019 EPS of $2.39-$2.43, versus the consensus of $2.41.

For earnings history and earnings-related data on Hologic (HOLX) click here.

You May Also Be Interested In

• Hologic recalls BioZorb markers after reported injuries - FDA
• General Mills (GIS) Tops Q4 EPS by 14c, Beats on Revenue; Offers FY27 EPS Guidance
• Biogen expects $164M R&D charge to hit Q2 2026 earnings